You are using a browser that has not been tested. Please upgrade your web browser to ensure the best experience with our website.

The diagnosis and management of axial spondyloarthritis

Tuesday 27 March, 2018 07:00 PM to Tuesday 27 March, 2018 08:00 PM (Australia/Melbourne)


Ticket Type End of Registration Price Quantity
MOVE Individual Member*
Unlimited 30.00 30.0 AUD
Unlimited 20.00 20.0 AUD
Non Member
Unlimited 45.00 45.0 AUD

*This price also applies to professional association members

Apply for Membership

       Donate Now         

The diagnosis and management of axial spondyloarthritis

Presenter: Dr Lionel Schachna, Rheumatologist, Austin Health, Melbourne

Description: Axial spondyloarthritis (SpA), whether with x-ray change (ankylosing spondylitis) or without x-ray change (non-radiographic axial SpA), is usually diagnosed many years after the onset of symptoms. Chronic back pain is common, and recognition of SpA in primary care requires a high index of suspicion and clinical acumen. MRI may be particularly useful in evaluating early presentations, although the chronic changes of sacroiliitis are often better seen on plain X-rays. First line treatment approaches include regular spinal stretching exercises and nonsteroidal anti-inflammatory drugs (NSAIDs). Particularly helpful for SpA patients are the biologic DMARDs that target tumour necrosis factor (TNF). TNF inhibitors strikingly improve symptoms and quality of life among most patients with axial SpA. A recent addition to the treatment armamentarium is an IL-17 inhibitor, secukinumab. Importantly, recent data suggest that the use of biologics for four years or longer can slow spinal fusion in patients with ankylosing spondylitis. These topics will be elaborated upon in the webinar entitled “Diagnosis and management of axial spondyloarthritis”.

About the Presenter: Dr Lionel Schachna runs the Austin Spondylitis Clinic in Melbourne. After completing rheumatology training at the Alfred Hospital and Monash Health, he completed a post-doctoral fellowship and PhD in clinical investigation at Johns Hopkins University in Baltimore. His research interests include epidemiologic studies in predictors of outcomes in axial spondyloarthritis.

Odoo text and image block


From Tuesday 27 March, 2018 07:00 PM
To Tuesday 27 March, 2018 08:00 PM


Musculoskeletal Australia
03 8531 8000
03 9530 0228

Join our E-Mailing List

Find us on social

Find us on Facebook Find us on Twitter Find us on Instagram Find us on LinkedIn